- Home
- APVO vs IVDA Comparison
APVO vs IVDA Comparison
Compare APVO & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- IVDA
- Stock Information
- Founded
- APVO 2016
- IVDA 2003
- Country
- APVO United States
- IVDA United States
- Employees
- APVO N/A
- IVDA N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- IVDA Computer Software: Prepackaged Software
- Sector
- APVO Health Care
- IVDA Technology
- Exchange
- APVO Nasdaq
- IVDA Nasdaq
- Market Cap
- APVO 4.9M
- IVDA 4.3M
- IPO Year
- APVO N/A
- IVDA N/A
- Fundamental
- Price
- APVO $1.78
- IVDA $1.58
- Analyst Decision
- APVO
- IVDA
- Analyst Count
- APVO 0
- IVDA 0
- Target Price
- APVO N/A
- IVDA N/A
- AVG Volume (30 Days)
- APVO 16.3M
- IVDA 5.5M
- Earning Date
- APVO 11-06-2025
- IVDA 11-13-2025
- Dividend Yield
- APVO N/A
- IVDA N/A
- EPS Growth
- APVO N/A
- IVDA N/A
- EPS
- APVO N/A
- IVDA N/A
- Revenue
- APVO N/A
- IVDA $7,142,302.00
- Revenue This Year
- APVO N/A
- IVDA $340.48
- Revenue Next Year
- APVO N/A
- IVDA N/A
- P/E Ratio
- APVO N/A
- IVDA N/A
- Revenue Growth
- APVO N/A
- IVDA 88.96
- 52 Week Low
- APVO $1.32
- IVDA $1.15
- 52 Week High
- APVO $381.10
- IVDA $8.05
- Technical
- Relative Strength Index (RSI)
- APVO 53.33
- IVDA 50.34
- Support Level
- APVO $1.41
- IVDA $1.46
- Resistance Level
- APVO $1.49
- IVDA $2.24
- Average True Range (ATR)
- APVO 0.18
- IVDA 0.17
- MACD
- APVO 0.04
- IVDA 0.04
- Stochastic Oscillator
- APVO 35.04
- IVDA 37.62
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).